Atlas Trials

Observational Study on the Use of Akynzeo® in Patients Receiving HEC

Clinical trial NCT03649230 · COMPLETED

Trial details

NCT number
NCT03649230
Sponsor
Purdue Pharma, Canada
Status
COMPLETED
Study type
OBSERVATIONAL
Chemotherapy-Induced Nausea and Vomiting
Start date
2018-10-03
Primary completion
2019-12-30
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.